{"id":45487,"date":"2022-06-24T17:01:38","date_gmt":"2022-06-24T15:01:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-g-protein-coupled-receptors-gpcrs-market-report-to-2027-developments-in-structural-biology-and-receptor-pharmacology-offer-novel-opportunities-researchandmarkets-com\/"},"modified":"2022-06-24T17:01:38","modified_gmt":"2022-06-24T15:01:38","slug":"global-g-protein-coupled-receptors-gpcrs-market-report-to-2027-developments-in-structural-biology-and-receptor-pharmacology-offer-novel-opportunities-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-g-protein-coupled-receptors-gpcrs-market-report-to-2027-developments-in-structural-biology-and-receptor-pharmacology-offer-novel-opportunities-researchandmarkets-com\/","title":{"rendered":"Global G-Protein Coupled Receptors (GPCRs) Market Report to 2027 – Developments in Structural Biology and Receptor Pharmacology Offer Novel Opportunities – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “G-Protein Coupled Receptors (GPCRs) – Global Market Trajectory & Analytics”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global market for G-Protein Coupled Receptors (GPCRs) estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$3.7 Billion by 2026, growing at a CAGR of 5.7% over the analysis period.\n<\/p>\n

\nCell Lines, one of the segments analyzed in the report, is projected to record a 5.6% CAGR and reach US$1.5 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Detection Kits segment is readjusted to a revised 6.3% CAGR for the next 7-year period.\n<\/p>\n

\nThe U.S. Market is Estimated at $1 Billion in 2021, While China is Forecast to Reach $296.6 Million by 2026<\/strong>\n<\/p>\n

\nThe G-Protein Coupled Receptors (GPCRs) market in the U.S. is estimated at US$1 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$296.6 Million by the year 2026 trailing a CAGR of 8.4% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 5.7% respectively over the analysis period.\n<\/p>\n

\nWithin Europe, Germany is forecast to grow at approximately 5.4% CAGR. North America is the largest GPCR market currently, owing to factors such as significant investments in cancer studies, increased emphasis on drug discovery and speedy approval of GPCR targeted drugs in the region. Growth in the Asia-Pacific region is set to be propelled by burgeoning population, rising incident of cancer, and increasing focus on contract research activities.\n<\/p>\n

\nCell Culture Reagents Segment to Reach $601.6 Million by 2026<\/strong>\n<\/p>\n

\nIn the global Cell Culture Reagents segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$370.6 Million in the year 2020 will reach a projected size of US$518.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$55.9 Million by the year 2026.\n<\/p>\n

\nSelect Competitors (Total 52 Featured) –<\/strong>\n<\/p>\n